Akèy › Tit travay › Senior Scientist
Senior Scientist: Salè H-1B
1,059 aplikasyon kondisyon travay te itilize tit travay Senior Scientist. Salè baz medyàn ofri $119,025; mwatye mitan $90,000–$139,470.
Demann (LCA)1,059
Salè medyan ofri$119,025
Mwatye salè yo$90,000–$139,470
10yèm–90yèm pousantaj$70,042–$153,566
Avoka imigrasyon, rekritè oswa anplwayè? Mete sèvis ou an tèt paj sa a — $99 pou 30 jou →
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|
| Washington University | 85 | $71,500 |
| Regeneron Pharmaceuticals, Inc. | 54 | $138,728 |
| Bristol-Myers Squibb Company | 43 | $145,340 |
| Icahn School of Medicine at Mount Sinai | 40 | $87,725 |
| Zoetis, Inc. | 33 | $100,000 |
| Pfizer Inc. | 31 | $94,702 |
| PPD Development, L.P. | 27 | $70,000 |
| AstraZeneca Pharmaceuticals LP | 25 | $125,840 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 23 | $129,957 |
| Sanofi US Services Inc. | 21 | $108,410 |
| MedImmune LLC | 20 | $121,903 |
| Takeda Development Center Americas, Inc. | 16 | $159,650 |
| Illumina, Inc. | 14 | $100,000 |
| Janssen Research & Development, LLC | 11 | $142,200 |
| Amgen Inc. | 11 | $152,515 |
| Alnylam US, Inc. | 10 | $151,000 |
| St. Jude Children's Research Hospital | 9 | $103,251 |
| Waters Technologies Corporation | 8 | $112,911 |
| Riconpharma, LLC | 8 | $97,650 |
| The University of Kansas Medical Center | 8 | $72,600 |
| The University of Virginia | 7 | $86,000 |
| Eurofins Lancaster Laboratories LLC | 7 | $63,443 |
| The Curators of the University of Missouri | 7 | $62,962 |
| Arcus Biosciences, Inc. | 7 | $152,000 |
| Philips North America LLC | 6 | $134,742 |
| Guardant Health, Inc. | 6 | $138,746 |
| Honda Research Institute USA, Inc. | 6 | $170,420 |
| TCG GreenChem, Inc | 6 | $94,706 |
| Simulations Plus, Inc. | 5 | $147,300 |
| Intellia Therapeutics | 5 | $147,450 |
| The Children's Hospital of Philadelphia | 5 | $101,379 |
| Eurofins Lancaster Laboratories Professional Scientific Services, LLC | 4 | $78,544 |
| 10x Genomics, Inc. | 4 | $144,500 |
| Navigate BioPharma Services, Inc. | 4 | $88,462 |
| TE Connectivity Corporation | 4 | $125,000 |
| Eli Lilly and Company | 4 | $102,690 |
| SolidEnergy Systems, LLC | 4 | $140,000 |
| GlaxoSmithKline LLC | 4 | $85,404 |
| Aon Re, Inc. | 4 | $105,000 |
| Washington University in St. Louis | 4 | $80,000 |
| Q-CTRL, Inc | 4 | $143,500 |
| DuPont Specialty Products USA, LLC | 4 | $125,376 |
| Axalta Coating Systems, LLC | 4 | $110,087 |
| University of Nebraska Medical Center | 4 | $72,362 |
| Orna Therapeutics, Inc. | 4 | $155,000 |
| Alkermes, Inc. | 4 | $150,000 |
| Fermi Forward Discovery Group, LLC | 4 | $135,976 |
| DuPont Electronic Materials International, LLC | 4 | $130,000 |
| Sanofi Vaccines US Inc. | 4 | $117,998 |
| Sutro Biopharma, Inc. | 3 | $150,000 |
| Granules Pharmaceuticals Inc. | 3 | $104,166 |
| HD Biosciences, Inc. | 3 | $115,149 |
| Genpharm International LLC | 3 | $145,860 |
| Pros Inc | 3 | $155,000 |
| Cyprotex US, LLC | 3 | $111,000 |
| Sanofi Pasteur Inc. | 3 | $105,331 |
| InvaGen Pharmaceuticals, Inc. | 3 | $120,175 |
| Abzena (Bristol) LLC | 3 | $130,000 |
| Sana Biotechnology, Inc. | 3 | $165,000 |
| Archer Daniels Midland Company | 3 | $125,000 |
Pa nivo salè
| Nivo revni | Salè medyan |
|---|
| Nivo I (antre) | $96,500 |
| Nivo II (kalifye) | $96,750 |
| Nivo III (eksperyans) | $126,099 |
| Nivo IV (plen kompetans) | $140,000 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|
| FY2023 | 228 | $105,897 |
| FY2024 | 288 | $112,916 |
| FY2025 | 278 | $123,800 |
| FY2026 | 229 | $127,000 |
Vil yo
- St. Louis, MO85
- Cambridge, MA81
- Tarrytown, NY53
- New York, NY47
- San Diego, CA41
- Gaithersburg, MD36
- South San Francisco, CA32
- Kalamazoo, MI32
- Waltham, MA28
- Ridgefield, CT20
- Middleton, WI16
- Boston, MA13
- Watertown, MA12
- Redwood City, CA12
- Philadelphia, PA12
- New Brunswick, NJ11
- San Jose, CA10
- Framingham, MA10
- Woburn, MA10
- Pearl River, NY10
- Columbia, MO10
- Memphis, TN9
- Houston, TX9
- Pleasanton, CA8
- Denville, NJ8
- Seattle, WA8
- Kansas City, KS8
- Lexington, MA8
- Palo Alto, CA7
- Marlborough, MA7
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).